[Syllabus]: Non-Mass Findings on Breast Ultrasound

Sona A. Chikarmane, MD

Sona A. Chikarmane, MD(bio)

  • Associate Professor of Radiology
  • Boston University Chobanian & Avedisian School of Medicine

Introduction

This syllabus reviews non-mass findings on breast ultrasound—a sonographic pattern not yet formalized in BI-RADS but increasingly recognized in the literature. Content spans evolving definitions and classification schemes, core sonographic criteria, internal echogenicity and distribution patterns, associated features with diagnostic value, inter-reader agreement data, and positive predictive values for malignancy. Emphasis is placed on multimodality correlation with mammography and MRI, biopsy strategy with rad–path concordance, and the broad pathologic spectrum (benign through malignant). Case-based pearls illustrate subtle detection, risk stratification, and practical management.

Definitions and Terminology

Non-mass findings on breast ultrasound refer to discrete areas of altered echotexture compared with adjacent parenchyma that do not meet criteria for a mass. Although not included in current BI-RADS lexicon, these findings are increasingly reported and clinically relevant for both detection and correlation with mammographic and MRI abnormalities.

Key Points

  • Definitions in the literature vary: “discrete altered echotexture,” “hypoechoic area different from surrounding tissue,” “visible in two planes without mass effect,” or “does not meet strict mass criteria.”
  • Requires conspicuity on two orthogonal planes and absence of a definable convex outer margin.
  • Recognition improves sonographic detection and supports mammographic/MRI correlation and biopsy targeting.

Historical Classification Systems

Multiple groups have proposed schemes based on ductal versus non-ductal morphology, echotexture, and distribution. Early work (e.g., a 2012 Japanese cohort) and subsequent proposals (2014–2015) categorized findings into ductal/non-ductal forms, pattern descriptors, and presence of associated features.

Key Points

  • Early schema: ductal (parallel, tubular structures; single or multiple) vs non-ductal hypoechoic areas (lacking convex borders; focal or segmental).
  • Pattern-based descriptors: mottled, indistinct, and geographic/cobblestone hypoechoic patterns.
  • Four-type systems incorporated associated features (calcifications, architectural distortion, posterior shadowing).
  • Distribution frameworks: focal, linear, segmental, regional—aligned with MRI and mammographic non-mass frameworks.
  • No standardized consensus; heterogeneity persists across studies.

Ultrasound Mass vs Non-Mass Lesion (NML)

Differentiation hinges on 3D morphology for masses versus pattern-based echotexture without a definable shape for NMLs. A recent educational review (J Breast Imaging, 2023) clarifies practical distinctions.

Key Points

  • Mass: 3D space-occupying lesion with shape and margins; seen in two planes; volumetric presence.
  • NML: discrete altered echotexture lacking definable shape/margin; must be conspicuous on orthogonal views.
  • Major NML features: internal echogenicity and distribution; associated features mirror those of masses (e.g., calcifications, ductal change, distortion, posterior shadowing, small cysts, hypervascularity).

Core Sonographic Criteria and Scanning Technique

Systematic scanning and verification across planes are critical to avoid overcalling physiologic heterogeneity as NML.

Key Points

  • Confirm conspicuity on two orthogonal planes; exclude artifacts and anisotropy.
  • Compare with adjacent quadrants and contralateral breast to gauge background parenchymal heterogeneity.
  • Absence of convex outer margins is essential; convexity favors a mass.
  • Expect interspersed normal fibroglandular or fatty tissue within NMLs (analogous to heterogeneous non-mass enhancement on MRI).

Internal Echogenicity Patterns

Echogenicity influences risk stratification and reporting clarity. Typical categories include predominantly hypoechoic, mixed hypo- and hyperechoic, and predominantly hyperechoic.

Key Points

  • Predominantly hypoechoic NMLs are common and often accompany posterior features.
  • Mixed echogenicity may reflect fibrosis, sclerosing processes, intralesional cysts, or carcinoma.
  • Predominantly hyperechoic NMLs occur (e.g., PASH, fibrous tissue) but can still warrant biopsy if suspicious or correlated with mammographic/MRI findings.

Distribution Patterns

Distribution parallels MRI lexicon and carries diagnostic implications.

Key Points

  • Focal: confined small area.
  • Linear: elongated along a duct.
  • Segmental: triangular/corded distribution oriented toward nipple (ductal tree).
  • Regional: large geographic area not conforming to a ductal unit.
  • Segmental distribution raises concern for DCIS or invasive processes, especially with calcifications or shadowing.

Associated Sonographic Features and Diagnostic Implications

Certain features materially increase the likelihood of malignancy and guide biopsy decisions.

Key Points

  • Calcifications within NML: high PPV; may indicate DCIS.
  • Ductal changes: tubular/branching hypoechoic structures; seen in both benign proliferative disease and DCIS.
  • Architectural distortion: radiating lines/straightening of Cooper’s ligaments; desmoplastic response can be benign (e.g., radial scar) or malignant.
  • Posterior shadowing: reflects stromal desmoplasia; seen in fibrosis and carcinoma.
  • Small interspersed cysts: occur in benign and malignant NMLs (occasionally DCIS).
  • Hypervascularity: supportive but nonspecific.

Inter-Reader Agreement and Epidemiology

Recent multi-reader data demonstrate moderate-to-substantial agreement but highlight definitional challenges.

Key Points

  • In a February 2025 study of 2,381 US-guided biopsies, 13.3% were categorized as NMLs.
  • Kappa for NML identification: 0.73; initial discordance mass vs NML occurred in ~32%, resolved on consensus.
  • Of NMLs, 42% were malignant; associated calcifications had the highest accuracy for malignancy (≈66%).
  • Approximately 31% of malignant NMLs lacked mammographic abnormalities, underscoring ultrasound’s incremental value.

Positive Predictive Values (PPVs) and Risk Stratification

Retrospective screening ultrasound data inform which features elevate malignancy risk.

Key Points

  • Features associated with malignancy: calcifications, posterior shadowing, segmental distribution, mixed echogenicity.
  • Reported PPVs:

- Microcalcifications: 44–100%

- Posterior shadowing: 22–95%

- Segmental distribution: 22–76%

- Non-parallel orientation: ~59%

  • Negative mammography correlates with lower malignancy rates and PPVs compared to positive mammography, but does not obviate biopsy of a suspicious NML.

Multimodality Correlation: Mammography

Mammographic correlates enhance risk assessment and guide targeting.

Key Points

  • Common correlates: asymmetry, focal asymmetry, and architectural distortion.
  • Clip localization after US-guided biopsy should be verified within the mammographic target to ensure rad–path concordance.
  • Discordant benign pathology with suspicious mammography warrants escalation (repeat biopsy or surgical excision).

Multimodality Correlation: MRI

MRI often shows non-mass enhancement that corresponds to sonographic NMLs.

Key Points

  • NMLs on ultrasound frequently correspond to NME on MRI (heterogeneous or homogeneous).
  • When MRI is the most conspicuous modality, MRI-guided biopsy may be preferable; otherwise US-guided biopsy is patient-friendly and efficient if a sonographic correlate exists.
  • High-risk patients (e.g., BRCA carriers) commonly show NME; targeted ultrasound can localize a biopsy target.

Pathologic Spectrum

NMLs encompass a wide range of pathologies; management hinges on imaging–pathology concordance and upgrade risk.

Key Points

  • Benign: fibrocystic change, epithelial hyperplasia, sclerosing adenosis/fibrosis, papilloma, mastitis/granulomatous mastitis, PASH, benign breast tissue, radial scar/complex sclerosing lesion.
  • Atypia/upgrade-prone: ADH, LCIS, complex sclerosing lesions with atypia.
  • Malignant: DCIS (common), invasive lobular carcinoma (common), invasive ductal carcinoma, mixed ductal–lobular carcinoma, special types (e.g., tubular, mucinous), rarely hematologic malignancies.
  • Literature reports 46–90% of NMLs are benign; malignancy rates vary by associated features and correlates.

Biopsy Strategy, Clip Placement, and Rad–Path Concordance

Accurate targeting and correlation are essential to safe management.

Key Points

  • Prefer US-guided biopsy when a confident sonographic correlate exists; consider MRI- or tomosynthesis-guided biopsy when appropriate.
  • Document distribution, echogenicity, and associated features to guide targeting (e.g., segmental calcifications, shadowing focus).
  • Verify post-biopsy clip position within the imaging target on mammography/MRI.
  • Manage discordance by deferring to the most suspicious imaging finding; consider repeat sampling or surgical excision.

Practical Pearls and Pitfalls

Subtlety and background heterogeneity create interpretive challenges; disciplined technique mitigates misses and misclassification.

Key Points

  • Always confirm visibility in two planes; beware of transient anisotropy and Cooper’s ligament artifacts.
  • Compare with contralateral regions to avoid overcalling physiologic echotexture.
  • Segmental linear ductal patterns with calcifications or shadowing deserve heightened suspicion.
  • Posterior shadowing is not synonymous with malignancy; interpret in context of distribution and correlates.
  • A negative mammogram should not delay biopsy of a suspicious NML.

Conclusion

Non-mass findings on breast ultrasound represent reproducible patterns of altered echotexture with clinically meaningful correlations across modalities. Despite variable definitions and lack of BI-RADS standardization, structured assessment of echogenicity, distribution, and associated features—combined with meticulous multimodality correlation—enables accurate targeting and risk stratification. Calcifications, posterior shadowing, and segmental patterns elevate malignancy probability; a negative mammogram does not preclude biopsy. Robust rad–path concordance with clip verification is central to management, recognizing the broad benign-to-malignant spectrum and potential for upgrade.

Ready to earn credit? Sign up for the Course.